Antimicrobial resistance (AMR) is a global health crisis, projected to cause up to 10 million deaths annually and impose economic costs exceeding $150 billion by 2050.

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés ...

Pharmacogenomics (PGx) is the study of how genetic variation affects the efficacy and safety of medicines, enabling ...

New OHE insight on immunisation: despite high returns on investment, global spending lags. We outline why and how countries ...

Analysis of Trump’s ‘Most Favoured Nation’ Executive Order on drug pricing, its global impact, price convergence aims, and ...

This calculator is built and hosted by OHE, and owned, funded, and commissioned by Pfizer. Before proceeding, please read the following important information regarding its use. This calculator ...

Rare disease medicine markets often rely on single suppliers, increasing the risk of shortages and limiting treatment options. Our report explores how supplier diversity can enhance healthcare ...

Our latest research shows respiratory infections cost UK businesses £44 billion a year. Workplace vaccination programs and health-focused policies could help boost productivity, reduce costs, and ...

To help inform the current debate on assisted dying, we have updated the findings of our 2019 palliative report with the latest data. A previous OHE report in 2019 estimated that 378, 427 people in ...